1. Home
  2. TMDX vs GVA Comparison

TMDX vs GVA Comparison

Compare TMDX & GVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TMDX
  • GVA
  • Stock Information
  • Founded
  • TMDX 1998
  • GVA 1922
  • Country
  • TMDX United States
  • GVA United States
  • Employees
  • TMDX N/A
  • GVA N/A
  • Industry
  • TMDX Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • GVA Military/Government/Technical
  • Sector
  • TMDX Health Care
  • GVA Industrials
  • Exchange
  • TMDX Nasdaq
  • GVA Nasdaq
  • Market Cap
  • TMDX 4.8B
  • GVA 4.1B
  • IPO Year
  • TMDX 2019
  • GVA 1990
  • Fundamental
  • Price
  • TMDX $122.68
  • GVA $109.60
  • Analyst Decision
  • TMDX Buy
  • GVA Strong Sell
  • Analyst Count
  • TMDX 9
  • GVA 1
  • Target Price
  • TMDX $123.00
  • GVA $76.00
  • AVG Volume (30 Days)
  • TMDX 1.3M
  • GVA 690.8K
  • Earning Date
  • TMDX 07-30-2025
  • GVA 08-07-2025
  • Dividend Yield
  • TMDX N/A
  • GVA 0.47%
  • EPS Growth
  • TMDX 2163.11
  • GVA 70.18
  • EPS
  • TMDX 2.02
  • GVA 3.11
  • Revenue
  • TMDX $531,292,000.00
  • GVA $4,078,324,000.00
  • Revenue This Year
  • TMDX $34.57
  • GVA $7.95
  • Revenue Next Year
  • TMDX $20.83
  • GVA $6.03
  • P/E Ratio
  • TMDX $61.12
  • GVA $35.16
  • Revenue Growth
  • TMDX 48.09
  • GVA 7.17
  • 52 Week Low
  • TMDX $55.00
  • GVA $69.08
  • 52 Week High
  • TMDX $177.37
  • GVA $111.43
  • Technical
  • Relative Strength Index (RSI)
  • TMDX 51.30
  • GVA 74.76
  • Support Level
  • TMDX $114.30
  • GVA $108.21
  • Resistance Level
  • TMDX $133.54
  • GVA $95.43
  • Average True Range (ATR)
  • TMDX 6.78
  • GVA 2.77
  • MACD
  • TMDX 0.98
  • GVA 1.11
  • Stochastic Oscillator
  • TMDX 51.17
  • GVA 93.41

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

About GVA Granite Construction Incorporated

Granite Construction Inc engages in the construction and development of various infrastructure projects on behalf of public and private clients in the United States. It focuses on heavy civil infrastructure projects, including roads, highways, transit facilities, airports, bridges, and other infrastructure projects. In addition, the company performs site preparation and infrastructure services for residential development, energy development, and other facilities. The majority of revenue is derived from the company's Construction operating segment, with the remainder derived from its Materials segment.

Share on Social Networks: